Cutaneous Leishmaniasis: a review focused in Costa Rica
Keywords:
Cutaneous Leishmaniasis, Costa RicaAbstract
Leishmaniasis is a complex of diseases caused by a heterogeneous group of protozoa belonging to the genus Leishmania sp. It is transmitted to humans through vectors, which in our country corresponds to mosquitoes. In Costa Rica, the province of Limón has the highest number of cases, concentrating mainly in the canton of Talamanca. There are 3 clinical forms, focusing this review on the cutaneous infection. Despite the significant number of cases that occur every year in the country, the management of the disease and the therapeutic options are not widespread among primary care physicians. There are some international guidelines such as those from the IDSA or the WHO; however, we do not have all the therapeutic options available to all doctors, even more so in the Social Security. The present review contemplates the clinical facts, diagnosis and treatment of cutaneous leishmaniasis with a focus from the Costa Rican reality.
References
2. Organización Mundial de la Salud (OMS) (2018). Leishmaniasis. Ginebra, Suiza: OMS. Extraído el 15 de octubre de 2018 desde http://www.who.int/es/news-room/fact-sheets/detail/leishmaniasis
3. Centers for Disease Control and Prevention (CDC) (2013). Parasites - Leishmaniasis. Atlanta, USA: CDC. Extraído el 15 de octubre de 2018 desde https://www.cdc.gov/parasites/leishmaniasis/biology.html
4. Aronson, N. Weller, P. Baron, E. (2018). Cutaneous leishmaniasis: Clinical manifestations and diagnosis en UptoDate. Waltham, MA: UpToDate Inc 2018. Extraído el 15 de octubre de 2018 desde https://www-uptodate.com.
5. Llanos-Cuenta, A. (2013). Leishmaniasis. En Parasitología humana. (1° ed). México: McGraw-Hill Medical.
6. Jaramillo-Antillón, O. Espinoza-Aguirre, A. Lobo-Philip, R. (2009) Estado Actual de la Leishmaniasis en Costa Rica. Acta Médica Costarricense, 51 (3), 158-164.
7. Méndez, M. López, J. (2016). Leishmaniasis visceral en Médula Ósea. Revista Clínica de la Escuela de Medicina UCR - HSJD, 6, 15-23.
8. Aparece raro caso de Leishmaniasis. (1995, Octubre 31). La Nación. Extraído el 15 de octubre de 2018 desde https://www.nacion.com/el-pais/salud/aparece-raro-caso-deleishmaniasis/HIZCUW2GN5HKTLLVHNIC3LBYHU/story/
9. Arenas, R. (2015). Leishmaniasis en Dermatología. Atlas de Diagnóstico y tratamiento (6° ed). México: McGraw-Hill Medical.
10. Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA) (2017). Oferta de Análisis de Laboratorio del Centro de Referencia en Virología. Extraído el 15 de octubre de 2018 desde http://www.inciensa.sa.cr/servicios/Matriz%20R40.pdf
11. Aronson, N. Herwaldt, B. Libman, M. Pearson, R. Lopez-Velez, R. Weina, P. Carvalho, E. Ephros, M. Jeronimo, M. Magill, A. (2016). Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical Infectious Diseases, 63 (15), e202-e264.
12. Organización Panamericana de la Salud (OPS) (2013). Leishmaniasis en las Américas: recomendaciones para el tratamiento. Washington, D.C.: OPS.
13. Unzun, S. Gürel, M. Durdu, M. Akyol, M. Karaman, B. Aksoy, M. Aytekin, S. Borlu, M. Doğan, E. Doğramac, S. Kapıcıoğlu, Y. Karakaş, A. Kaya, T. Mülayim, M. Özbel, Y. Töz, S. Özgöztaş, O. Yeşilova, Y. Harman, M. (2018). Tropical medicine round. Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. International Journal of Dermatology. Aug; 57(8), 973-982.
14. Aronson N, Weller P, Baron E. (2018). Cutaneous leishmaniasis: Treatment en UpToDate. Waltham, MA: UpToDate Inc. Extraído el 15 de octubre de 2018 desde https://www-uptodate.com
15. Ministerio de Salud de Costa Rica (2019). Productos registrados. San José, Costa Rica: Ministerio de Salud. Extraído el 15 de octubre de 2018 desde https://www.ministeriodesalud.go.cr/index.php/informacion/productos-registrados
16. López, L. Vélez, I. Asela, C. Cruz, C. Alves, F. Robledo, S. Arana, B. (2018). A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia. Neglected Tropical Diseases, 12 (7), 1-12.
17. Gonçalves SVCB, Costa CHN. (2018). Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study. Anais Brasileiros de Dermatologia, 93(3), 347-55.
18. Sainz-Gaspar, L. Rosón, E. Llovo, J. Vásquez-Vega, H. (2018). Terapia fotodinámica en el tratamiento de la leishmaniasis cutánea. Actas Dermosifiliográficas, 109(5), e33–e36.
19. Organización Panamericana de la Salud (OPS) (2013). Informe Final: Segunda Reunión de Gerentes de Programas de Leishmaniasis en las Américas. Ciudad de Panamá, Panamá: OPS.
20. Caja Costarricense del Seguro Social (CCSS) (2019). Lista Oficial de Mediamentos. San José, Costa Rica: CCSS.
21. Sundar, S. Singh, B. (2018). Emerging therapeutic targets for treatment of leishmaniasis. Expert Opinion on Therapeutics Targets, 22 (6), 467- 486.
22. Oryan, A. Bemani, E. Bahrami, S. (2018). Emerging role of amiodarone and dronedarone, as antiarrhythmic drugs, in treatment of leishmaniasis. Acta Tropical, 22 (185), 34-41.
Downloads
Published
Issue
Section
License
The intellectual property of accepted works belongs to their authors, however access to them is totally open and free, so they can be reproduced totally or partially with the only limitation of recognizing the authorship and the source of publication (Revista Medicina Legal de Costa Rica), as long as said exploitation does not have commercial character.
